PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Report from the front lines of personalized reproductive medicine revolution

Dr. Piraye Yurttas Beim paints optimistic future for women struggling with infertility at Futures of Reproduction Conference in Cambridge, UK

Report from the front lines of personalized reproductive medicine revolution
2012-12-15
(Press-News.org) Cambridge, UK (December 15, 2012)--Piraye Yurttas Beim, PhD, Founder and CEO of the biotech firm Celmatix Inc., and a leading international expert in the genetics of female infertility, presented A Report from the Front Lines of the Personalized Reproductive Medicine Revolution at the Futures in Reproduction Conference at the Churchill College, Cambridge, a two- day meeting celebrating the spirit of inquiry personified by Nobel Prize winner Professor Sir Robert Edwards.

In the not so distant future, Dr. Beim predicts things will be very different for women who struggle with infertility. The pairing of "big data" analytics with genomics is helping Celmatix decipher the genetic drivers of infertility and usher in an era of personalized reproductive medicine by determining which treatments work best for individuals and developing targeted therapies and treatment plans, something that is being done in cancer treatment already.

Celmatix uses big data and the power of machine learning analytics to interpret personalized clinical data, such as hormone levels and age, to understand how specific patients compare to millions of other women with similar conditions. By pairing these analytics with the world's first whole genome sequences of women with unexplained infertility and premature menopause, Celmatix is paving the way for personalized treatments and recommendations.

"We're here to celebrate Bob Edwards' dream, and the conviction that it's possible to overcome infertility," said Dr. Beim. "This is a very exciting time for reproductive medicine. Scientists are helping women extend their biological lifespan through gamete and embryo preservation, and the majority of couples who are able to persist with fertility treatments such as IVF achieve the goal of starting a family."

"But challenges still remain," she adds. "The people who are least likely to benefit from current treatments often end up in the system for the longest, with round after round of failed cycles. And even people who succeed often have to go through several failed treatment cycles until physicians determine what finally works through a sequential process of trial and failure."

Dr. Beim says the statistics are compelling: 68% of IVF treatment cycles in women under 40 do not result in a live birth. Of 7.3 million American women with infertility problems, about 40% pursue treatment, while the other 60% avoid what they fear will be an expensive and emotionally taxing process. And, infertility is a global issue. Approximately 56% of assisted reproductive technology (ART) procedures are performed in Europe. In addition to the large European market, roughly 50 million couples in China and India are currently seeking infertility treatment.

However, she says, change is on the horizon. Cancer patients are already benefiting from the use of targeted therapies and companion diagnostics, and the time is ripe for the reproductive medicine field to start leveraging these powerful personalized paradigms. The cost of DNA sequencing and data storage is plummeting and there is widespread adoption of electronic medical records, which not only help collect big data and assist in the development of bio repositories but store a valuable body of personal phenotypic data that can help shape/direct individualized treatment when evaluated through sophisticated analytics.

"Look at what has happened in the 12 short years since the first genome was sequenced," says Dr. Beim. "We now have 30,000 genomes sequenced, and we've all heard that the $1000 genome is just around the corner. But reproductive medicine faces unique challenge, and several pieces of the puzzle need to come together before we solve the riddle of infertility and reduce the 'noise' in our datasets to simplify the problem."

Dr. Beim explained that Celmatix is tackling the problem by pairing big data analytics with genomics; building the FertilomeTM Database as a filtering tool and discovery engine; and looking at possible biomarkers for infertility. This work will lead over the coming years to the development of the world's first noninvasive, companion genetic diagnostic test to guide infertility treatment and identify women at risk for premature menopause.

"Understanding the genetic drivers of infertility is step one in the direction of personalizing reproductive medicine," she says. "Having diagnostics that can differentiate who treatments work for better than others is good first step. But the real promise is then to be able to pair this information with targeted therapies. "



INFORMATION:

About Celmatix Inc.

Founded in 2009, Celmatix Inc. is a venture-backed biotechnology company committed to streamlining the diagnoses and treatment of female infertility. By integrating genetic diagnostics and analytics, Celmatix is enabling a future where physicians will be able to better interpret clinical data, clarify the causes of treatment failure, and make personalized recommendations about paths to effective fertility treatments. The company is currently developing a noninvasive diagnostic test to assess the genetic indicators underlying egg quality and female infertility, permitting reproductive specialists to assess potential problems at the beginning of the treatment process in order to develop optimal treatment paths, plan for egg preservation, and pre-screen prospective egg donors, if necessary. For more information visit www.celmatix.com

CONTACT: Rubenstein Associates, Inc., Public Relations
Nadine Woloshin at 212-843-8041/917-699-9456/nwoloshin@rubenstein.com
Jane Rubinstein at 212-843-8287/516-993-0708/jrubinstein.com


[Attachments] See images for this press release:
Report from the front lines of personalized reproductive medicine revolution

ELSE PRESS RELEASES FROM THIS DATE:

Impaired executive function may exacerbate impulsiveness and risk of developing alcohol dependence

2012-12-15
Executive function (EF), frequently associated with the frontal lobes, guides complex behavior such as planning, decision-making, and response control. EF impairment due to alcohol dependence (AD) has been linked to alcohol's toxic effects on the frontal lobes. A study of EF in a group of adult offspring of AD individuals has found that increased impulsiveness and decreased EF may comprise an inherited trait that signifies greater risk for developing AD. Results will be published in a special online issue of Alcoholism: Clinical & Experimental Research and are currently ...

Negative emotionality may make some people more prone to alcohol or other drug problems

2012-12-15
Prior research has shown that sensitivity to the stimulating effects of alcohol and other drugs is a risk marker for heavy or problematic use of those substances. Prior research has also shown that the personality trait of negative emotionality can have an effect on substance use. A new study examining how the response to an amphetamine interacts with negative emotionality to influence alcohol and drug use has found that a high level of negative emotionality may lead to problem drinking when it occurs together with sensitivity to a drug-based reward. Results will be ...

Alcohol marketers use drinker identity and brand allegiance to entice underage youth

2012-12-15
While exposure to alcohol marketing is prevalent, and associated with both initiation and progression of alcohol use in underage youth, exactly how it works is not well understood. A new study of alcohol-specific cognitions – whether someone thinks of him/herself as a drinker or having a favorite brand of alcohol – has found that drinker identity and brand allegiance are indeed factors linking alcohol marketing and problematic drinking among experimental underage drinkers. Results will be published in a special online issue of Alcoholism: Clinical & Experimental Research ...

Early drunkenness may be riskier than an early age at first drink for problem behaviors

2012-12-15
Contact: Emmanuel Kuntsche ekuntsche@addictionsuisse.ch 41-213-212-952 Addiction Switzerland Contact: Allaman Allamani allamana@gmail.com 39-55-462-4331 (Italy) Regional Health Agency, Tuscany Alcoholism: Clinical & Experimental Research Early drunkenness may be riskier than an early age at first drink for problem behaviors Many researchers and clinicians believe that an early age at first drink (AFD) can lead to alcohol problems. A new study challenges that belief by examining linkages between AFD and problem behaviors. Findings show that early ...

Vitamin D deficiency may contribute to alcohol-related muscular weakness

2012-12-15
Contact: Jan W. Wijnia j.wijnia@zorggroeprijnmond.nl 31-102-931-555 Slingedael Korsakoff Center Contact: Frits A. J. Muskiet f.a.j.muskiet@umcg.nl 31-50-361-2733 or 9228 University Medical Center Groningen Alcoholism: Clinical & Experimental Research Vitamin D deficiency may contribute to alcohol-related muscular weakness Myopathy refers to a disease characterized by muscular weakness and wasting. Vitamin D deficiency is a well-recognized cause of myopathy, and excessive drinking is often associated with low or subnormal levels of vitamin D. A ...

Chronic alcohol and marijuana use during youth can compromise white-matter integrity

2012-12-15
Chronic use of alcohol and marijuana during youth is associated with poorer neural structure, function, and metabolism, as well as worsened neurocognitive abilities into later adolescence and adulthood. This may be due to biological and psychosocial transitions occurring during adolescence that impart increased vulnerability to neurotoxic influences. A study of longitudinal changes in fiber tract integrity associated with adolescent alcohol and marijuana use during 1.5 years supports previous findings of reduced white-matter integrity in these youth. Results will be ...

The mu opioid receptor genotype may be a marker for those who drink for alcohol's rewarding effects

2012-12-15
Previous research had identified an individual's subjective response to alcohol as a marker of alcoholism risk. The A118G single nucleotide polymorphism (SNP) of the mu opioid receptor (OPRM1) gene had also been previously associated with subjective response to alcohol in heavy drinkers. A new study extends this research, showing that the OPRM1 genotype seems to moderate the pleasant and stimulating effects to alcohol among alcohol-dependent (AD) individuals but not its unpleasant and sedative effects. Results will be published in a special online issue of Alcoholism: ...

Study is first to find significant link between sleepiness and vitamin D

2012-12-15
DARIEN, IL – A new study suggests that there is a significant correlation between excessive daytime sleepiness and vitamin D, and race plays an important factor. Results show that in patients with normal vitamin D levels, progressively higher levels of daytime sleepiness were correlated inversely with progressively lower levels of vitamin D. Among patients with vitamin D deficiency, sleepiness and vitamin D levels were associated only among black patients. Surprisingly, this correlation was observed in a direct relationship, with higher vitamin D levels associated ...

Low adiponcetin associated with increased pancreatic cancer risk

2012-12-15
Low prediagnostic levels of circulating adiponectin were associated with an increased risk of pancreatic cancer, according to a study published December 14 in the Journal of the National Cancer Institute. Pancreatic cancer is the fourth leading cause of cancer death in the U.S., but its etiology remains unclear. Adiponectin, a hormone secreted from fat cells, has insulin-sensitizing and anti-inflammatory properties. Low adiponectin plasma levels are associated with the insulin resistance that manifests in obesity and diabetes mellitus, both of which are risk factors ...

McLean study finds long-term anabolic-androgenic steroid use may impact visuospatial memory

2012-12-15
Belmont, MA—The long-term use of anabolic-androgenic steroids (AAS) may severely impact the user's ability to accurately recall the shapes and spatial relationships of objects, according to a recent study conducted by McLean Hospital and Harvard Medical School investigators. In the study, published today online in the journal Drug and Alcohol Dependence, McLean Hospital Research Psychiatrist Harrison Pope, MD, used a variety of tests to determine whether AAS users developed cognitive defects due to their admitted history of abuse. "Our work clearly shows that while ...

LAST 30 PRESS RELEASES:

No evidence that substituting NHS doctors with physician associates is necessarily safe

At-home brain speed tests bridge cognitive data gaps

CRF appoints Josep Rodés-Cabau, M.D., Ph.D., as editor-in-chief of structural heart: the journal of the heart team

Violent crime is indeed a root cause of migration, according to new study

Customized smartphone app shows promise in preventing further cognitive decline among older adults diagnosed with mild impairment

Impact of COVID-19 on education not going away, UM study finds

School of Public Health researchers receive National Academies grant to assess environmental conditions in two Houston neighborhoods

Three Speculum articles recognized with prizes

ACM A.M. Turing Award honors two researchers who led the development of cornerstone AI technology

Incarcerated people are disproportionately impacted by climate change, CU doctors say

ESA 2025 Graduate Student Policy Award Cohort Named

Insomnia, lack of sleep linked to high blood pressure in teens

Heart & stroke risks vary among Asian American, Native Hawaiian & Pacific Islander adults

Levels of select vitamins & minerals in pregnancy may be linked to lower midlife BP risk

Large study of dietary habits suggests more plant oils, less butter could lead to better health

Butter and plant-based oils intake and mortality

20% of butterflies in the U.S. have disappeared since 2000

Bacterial ‘jumping genes’ can target and control chromosome ends

Scientists identify genes that make humans and Labradors more likely to become obese

Early-life gut microbes may protect against diabetes, research in mice suggests

Study raises the possibility of a country without butterflies

Study reveals obesity gene in dogs that is relevant to human obesity studies

A rapid decline in US butterfly populations

Indigenous farming practices have shaped manioc’s genetic diversity for millennia

Controlling electrons in molecules at ultrafast timescales

Tropical forests in the Americas are struggling to keep pace with climate change

Brain mapping unlocks key Alzheimer’s insights

Clinical trial tests novel stem-cell treatment for Parkinson’s disease

Awareness of rocky mountain spotted fever saves lives

Breakthrough in noninvasive monitoring of molecular processes in deep tissue

[Press-News.org] Report from the front lines of personalized reproductive medicine revolution
Dr. Piraye Yurttas Beim paints optimistic future for women struggling with infertility at Futures of Reproduction Conference in Cambridge, UK